Correction: Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity

Correction: Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity

Saved in:

Bibliographic Details
Main Authors:	Hongqiang Zhang, Zhixin Tu, Sihua Liu, Jumei Wang, Jie Shi, Xingyu Li, Rongdongqing Shi, Minghui Chen, Tong Yue, Sihui Luo, Yu Ding, Xueying Zheng
Format:	Article
Language:	English
Published:	BMC 2025-05-01
Series:	Cardiovascular Diabetology
Online Access:	https://doi.org/10.1186/s12933-025-02794-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity
by: Hongqiang Zhang, et al.
Published: (2025-01-01)

The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease
by: Xin Gao, et al.
Published: (2025-05-01)

Insulin resistance surrogates are associated with all-cause mortality and cardiovascular mortality in population with metabolic syndrome: a retrospective cohort study of NHANES
by: Jinhao Liao, et al.
Published: (2025-02-01)

Exploring the synergistic effects of Life’s Essential 8, insulin resistance, and CRP on cardiometabolic multimorbidity risk
by: Jiang Liu, et al.
Published: (2025-07-01)

Association Between Cardiometabolic Multimorbidity and 15-year Mortality in the Asia Cohort Consortium
by: Sangjun Lee, et al.
Published: (2025-07-01)

Joint association of air pollutants on cardiometabolic multimorbidity
by: Liang Xia, et al.
Published: (2024-11-01)

Cardiometabolic multimorbidity and neuropsychiatric disturbances in multiregional older adults
by: Haoran Zhang, et al.
Published: (2024-10-01)

Clinical Characteristics and Medication Patterns of Patients with Cardiometabolic Multimorbidity
by: ZHENG Xiaomeng, ZHOU Xuan, SUN Yu, FAN Miao, JIN Yiyi, ZHU Suyan
Published: (2025-03-01)

Adiposity, circulating metabolic markers, and risk of cardiometabolic multimorbidity
by: Si Cheng, et al.
Published: (2025-04-01)

Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study.
by: Archana Singh-Manoux, et al.
Published: (2018-05-01)

Association of clonal hematopoiesis of indeterminate potential with cardiometabolic multimorbidity progression and mortality: a prospective study of UK Biobank
by: Chenzhe Zuo, et al.
Published: (2025-05-01)

Association of cardiometabolic index with all-cause and cardiovascular mortality among middle-aged and elderly populations
by: Mengya Zhu, et al.
Published: (2025-01-01)

Associations of cardiometabolic multimorbidity with all-cause dementia, alzheimer’s disease, and vascular dementia: a cohort study in the UK biobank
by: Junrun Zhang, et al.
Published: (2025-07-01)

Association of impaired fasting glucose with cardiometabolic multimorbidity: The Kailuan study
by: Zhihui Guo, et al.
Published: (2025-01-01)

Effect of PM2.5 and its constituents on hospital admissions for cardiometabolic multimorbidity in Urumqi, China
by: Di Wu, et al.
Published: (2025-02-01)

Cardiometabolic markers and serum amh levels in PCOS: can AMH serve as a surrogate cardiometabolic markeR?
by: Mohammad Ashraf Ganie, et al.
Published: (2025-03-01)

Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank
by: Zhenyu Tian, et al.
Published: (2025-06-01)

Serum Amylase Levels in T2DM Patients: Surrogate Biomarker of Cardiometabolic Status
by: M. Rasheed Khan, et al.
Published: (2025-01-01)

Trends in cardiometabolic multimorbidity in non-elderly adult Medicaid enrollees, 2018–2022
by: Puneet Kaur Chehal, et al.
Published: (2025-06-01)

Vitamin D status, vitamin D receptor polymorphisms, and risk of cardiometabolic multimorbidity
by: Jianhua Ma, et al.
Published: (2025-05-01)

Association between cardiometabolic multimorbidity, body roundness index, and frailty index in Chinese middle-aged and older adults
by: Xiaoming Zhang, et al.
Published: (2025-02-01)

The TG/HDL-C Ratio Might Be a Surrogate for Insulin Resistance in Chinese Nonobese Women
by: Jiyun He, et al.
Published: (2014-01-01)

Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset.
by: Corey L Nagel, et al.
Published: (2025-01-01)

Relationship of METS-IR with cardiometabolic multimorbidity in China: a nationwide longitudinal cohort study
by: Chunyan Zhou, et al.
Published: (2025-02-01)

Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation
by: Dun Li, et al.
Published: (2025-06-01)

Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset
by: Corey L. Nagel, et al.
Published: (2025-01-01)

Adherence to life’s essential 8 and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study
by: Hao Bai, et al.
Published: (2025-06-01)

Associations of metabolic heterogeneity of obesity with the progression of cardiometabolic multimorbidity—a nationwide prospective cohort study
by: Nian Cai, et al.
Published: (2025-08-01)

The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity
by: Bingen Wan, et al.
Published: (2025-04-01)

Cardiometabolic multimorbidity and frailty in middle-aged and older adults: a cross-nationally harmonized study
by: Kunyan Zhou, et al.
Published: (2025-04-01)

Shiftwork and insulin resistance in professional drivers: exploring the association using non-insulin-based surrogate measures
by: Mirella Youssef Tawfik, et al.
Published: (2025-01-01)

Unveiling the Significance of Surrogate Markers of Insulin Resistance in Metabolic Health Assessment
by: Najmunnissa, et al.
Published: (2024-05-01)

Multimorbidity and mortality: A data science perspective
by: Kien Wei Siah, et al.
Published: (2022-05-01)

Multimorbidity and the combination of chronic non-communicable diseases and their relationship to all-cause mortality among Costa Rican older adults
by: Beatriz Novak
Published: (2024-10-01)

Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study
by: Lingqu Zhou, et al.
Published: (2025-05-01)

Insulin resistance assessed by estimated glucose disposal rate is associated with all-cause and cardiovascular mortality among postmenopausal women
by: Han Qian, et al.
Published: (2025-07-01)

Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence.
by: Jairo M Montezuma-Rusca, et al.
Published: (2016-01-01)

Cardiometabolic index and mortality risks: elevated cancer and reduced cardiovascular mortality risk in a large cohort
by: Junjie Wang, et al.
Published: (2024-12-01)

Linking cardiometabolic multimorbidity to depressive symptoms in the oldest-old: results from a cross-sectional study in Germany
by: Verena Maschke, et al.
Published: (2025-05-01)

Association of Systemic Inflammatory Response Index with the cardiometabolic multimorbidity among US adults: A population-based study
by: Jing Li, et al.
Published: (2025-01-01)